PROGENICS PHARMACEUTICALS IN

CUSIP: 743187106 Class: CMN

Swiss National Bank's Holding History (CIK: 0001582202)

Note: Option positions (PUT/CALL) are excluded.

Q1 2020
Shares 165,500 Value ($000) $629 Avg Close — Range —
Q4 2019
Shares 165,500 Value ($000) $842 Avg Close — Range —
Q3 2019
Shares 159,100 Value ($000) $804 Avg Close — Range —
Q2 2019
Shares 154,100 Value ($000) $951 Avg Close — Range —
Q1 2019
Shares 154,100 Value ($000) $715 Avg Close — Range —
Q4 2018
Shares 147,400 Value ($000) $619 Avg Close — Range —
Q3 2018
Shares 147,400 Value ($000) $924 Avg Close — Range —
Q2 2018
Shares 122,400 Value ($000) $984 Avg Close — Range —
Q1 2018
Shares 122,400 Value ($000) $913 Avg Close — Range —
Q4 2017
Shares 115,700 Value ($000) $688 Avg Close — Range —
Q3 2017
Shares 115,700 Value ($000) $852 Avg Close — Range —
Q2 2017
Shares 115,700 Value ($000) $786 Avg Close — Range —
Q1 2017
Shares 115,700 Value ($000) $1,092 Avg Close — Range —
Q4 2016
Shares 115,700 Value ($000) $1,000 Avg Close — Range —
Q3 2016
Shares 115,700 Value ($000) $732 Avg Close — Range —
Q2 2016
Shares 115,700 Value ($000) $488 Avg Close — Range —
Q1 2016
Shares 115,700 Value ($000) $487 Avg Close — Range —
Q4 2015
Shares 94,500 Value ($000) $579 Avg Close — Range —
Q3 2015
Shares 94,500 Value ($000) $541 Avg Close — Range —
Q2 2015
Shares 82,800 Value ($000) $618 Avg Close — Range —